Repro Med Systems Inc (KRMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Repro Med Systems Inc (KRMD) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($65.46K) by net assets ($16.46 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Repro Med Systems Inc - Cash Flow Conversion Efficiency Trend (1996–2024)
This chart illustrates how Repro Med Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Repro Med Systems Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Repro Med Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Repro Med Systems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Frauenthal Holding AG
VI:FKA
|
-0.040x |
|
OrganiGram Holdings Inc
TO:OGI
|
-0.043x |
|
Hawesko Holding AG
XETRA:HAW
|
-0.017x |
|
Sinphar Pharmaceutical Co Ltd
TW:1734
|
0.054x |
|
Starrag Group Holding AG
SW:STGN
|
0.103x |
|
Eastech Holding Limited
TW:5225
|
0.042x |
|
Oriental Interest Bhd
KLSE:5827
|
0.045x |
|
Gulf Island Fabrication Inc
NASDAQ:GIFI
|
0.030x |
Annual Cash Flow Conversion Efficiency for Repro Med Systems Inc (1996–2024)
The table below shows the annual cash flow conversion efficiency of Repro Med Systems Inc from 1996 to 2024. For the full company profile with market capitalisation and key ratios, see Repro Med Systems Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $16.81 Million | $-319.72K | -0.019x | +92.09% |
| 2023-12-31 | $20.35 Million | $-4.89 Million | -0.240x | -39.33% |
| 2022-12-31 | $31.33 Million | $-5.40 Million | -0.173x | -45.79% |
| 2021-12-31 | $36.50 Million | $-4.32 Million | -0.118x | -475.63% |
| 2020-12-31 | $36.16 Million | $-743.32K | -0.021x | -172.05% |
| 2019-12-31 | $11.24 Million | $320.62K | 0.029x | -82.72% |
| 2018-12-31 | $8.96 Million | $1.48 Million | 0.165x | +40.73% |
| 2017-12-31 | $7.67 Million | $899.91K | 0.117x | +336.21% |
| 2016-12-31 | $6.68 Million | $-331.62K | -0.050x | -117.56% |
| 2015-12-31 | $6.77 Million | $1.91 Million | 0.283x | +114.76% |
| 2014-12-31 | $6.27 Million | $826.10K | 0.132x | -28.37% |
| 2013-12-31 | $5.19 Million | $954.39K | 0.184x | +2.05% |
| 2012-12-31 | $4.36 Million | $784.79K | 0.180x | +14.10% |
| 2011-12-31 | $3.55 Million | $560.60K | 0.158x | -67.34% |
| 2010-12-31 | $2.13 Million | $1.03 Million | 0.483x | +30.72% |
| 2009-12-31 | $1.03 Million | $382.30K | 0.370x | -50.62% |
| 2008-12-31 | $705.09K | $528.18K | 0.749x | +483.59% |
| 2007-12-31 | $-602.26K | $117.61K | -0.195x | -247.35% |
| 2006-12-31 | $-645.83K | $-85.59K | 0.133x | -45.57% |
| 2005-12-31 | $-569.82K | $-138.75K | 0.243x | -51.70% |
| 2004-12-31 | $-380.26K | $-191.69K | 0.504x | +150.37% |
| 2003-12-31 | $-173.46K | $-34.92K | 0.201x | -32.76% |
| 2002-12-31 | $61.19K | $18.32K | 0.299x | +315.55% |
| 2001-12-31 | $337.38K | $-46.87K | -0.139x | +29.35% |
| 2000-12-31 | $694.45K | $-136.56K | -0.197x | -234.46% |
| 1999-12-31 | $657.91K | $96.22K | 0.146x | +171.80% |
| 1998-12-31 | $540.00K | $-110.00K | -0.204x | -15.43% |
| 1997-12-31 | $1.87 Million | $-330.00K | -0.176x | -266.50% |
| 1996-12-31 | $2.17 Million | $230.00K | 0.106x | -- |
About Repro Med Systems Inc
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating p… Read more